FDA HEALTH CLAIM FINAL RULE STAY-OF-ACTION SOUGHT
This article was originally published in The Tan Sheet
FDA HEALTH CLAIM FINAL RULE STAY-OF-ACTION SOUGHT by a coalition including the American Preventive Medical Association, Citizens for Health, National Health Federation, and supplement manufacturers Durk Pearson and Sandy Shaw. In a Jan. 21 petition to FDA submitted by counsel Jonathan Emord (Silver Spring, Md. law firm Alexander, Gebhardt, Aponte & Marks), the group insisted that the agency's Jan. 4 final rule disallowing health claims for five nutrient-disease relationships ("The Tan Sheet" Jan. 3, p. 7) violates First Amendment rights and therefore should be stayed.
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC